Tuberculosis

Question 1

Children 6-11 years

Question 2

Personalized asthma management:

Question 3

Assess

Answer 3

Adjust

Question 4

NEW RESPONSE

Question 5

Symptoms

Question 6

Exacerbations

Question 7

Side-effects

Question 8

Lung function

Question 9

Child and parent

Question 10

satisfaction

Question 11

Asthma medication options:

Question 12

Adjust treatment up and down for

Question 13

individual child’s needs

Question 14

PREFERRED

Question 15

CONTROLLER

Question 16

to prevent exacerbations

Question 17

and control symptoms

Question 18

Other

Question 19

controller options

Question 20

RELIEVER

Question 21

STEP 1

Question 22

Low dose ICS

Question 23

taken whenever

Question 24

SABA taken*; or

Question 25

daily low dose ICS

Question 26

ADJUST

Question 27

DO NO

Question 28

STEP 2

Question 29

Daily low dose inhaled corticosteroid (ICS)

Question 30

(see table of ICS dose ranges for children)

Question 31

Leukotriene receptor antagonist (LTRA)

Answer 31

or

Question 32

low dose ICS taken whenever SABA taken*

Question 33

Confirmation of diagnosis if necessary

Question 34

Symptom control & modifiable

Question 35

risk factors (including lung function)

Question 36

Comorbidities

Question 37

Inhaler technique & adherence

Question 38

Child and parent goals

Question 39

ASSESS

Question 40

OR DISTR

Question 41

Treatment of modifiable risk factors

Question 42

& comorbidities

Question 43

Non-pharmacological strategies

Question 44

Education & skills training

Question 45

Asthma medications

Question 46

STEP 3

Question 47

Low dose

Question 48

ICS-LABA

Question 49

or medium

Question 50

dose ICS

Question 51

Low dose

Question 52

ICS + LTRA

Question 53

STEP 4

Question 54

Medium dose

Question 55

ICS-LABA

Question 56

Refer for

Question 57

expertadvice

Question 58

High dose ICS-

Question 59

LABA

Answer 59

or add-

Question 60

on tiotropium

Question 61

or add-on LTRA

Question 62

44859

Question 63

As-needed short-acting B

Answer 63

-agonist (SABA)

Question 64

• Off-label; separate ICS and SABA inhalers; only one study in children

Question 65

Pharmagate 2023

Question 66

STEP 5

Question 67

Refer for

Question 68

phenotypic

Question 69

assessment

Question 70

+ add-on

Question 71

therapy

Question 72

e.g. anti-IgE

Question 73

Add-on anti-IL5

Question 74

or add-on low

Question 75

dose OCS

Question 76

but consider

Question 77

side-effects

Question 78

113